Amazon recently announced a pilot program aimed at deploying prescription dispensing kiosks inside One Medical clinics in Los Angeles. The pilot is designed to allow patients to receive medications within minutes of a clinical visit, supported by on-demand pharmacist consultations. Amazon positions the model as a tool to reduce primary nonadherence by eliminating the delay between prescribing and fulfillment. Community pharmacy stakeholders, however, caution that limited on-site formularies and remote-only pharmacist interactions risk reducing pharmacy care to a transactional service rather than a longitudinal clinical function. For pharmacies considering deploying their own clinic-based kiosk models, the opportunity is significant but carries meaningful legal, regulatory, and contractual risk. Before launching a kiosk program, pharmacies should carefully evaluate Board of Pharmacy requirements, Anti-Kickback Statute (AKS) exposure, and pharmacy benefit manager (PBM) contracting implications.
Amazon’s Kiosk Model
Amazon’s kiosk approach relies on automated dispensing units stocked with a curated set of commonly prescribed medications. Each prescription is verified by a licensed pharmacist, with patient counseling delivered via video or telephone when required. Prescriptions outside the kiosk’s inventory are routed to Amazon’s digital pharmacy for home delivery, with same-day service. The pilot is launching at select One Medical sites in Los Angeles, with inventory calibrated to local prescribing patterns. Amazon characterizes the kiosks as complementary to existing pharmacy channels, grounded in the premise that collapsing the distance between the exam room and medication access can meaningfully improve therapy initiation.
In theory, providing medication at the point of care, paired with pharmacist consultation, could accelerate time to first dose and improve early adherence, particularly for patients facing transportation or scheduling barriers. The model also aspires to integrate pharmacists more closely into the care episode by synchronizing counseling with the clinic visit.
The model also depends on continuously updated prescribing data, as lagging or static inventory algorithms could exacerbate stockouts for time-sensitive therapies. Even where prescriber discretion is preserved, the visibility of stocked medications may create default behaviors that clinics should proactively address through clear prescribing governance.
Opportunities, Challenges, and Legal Considerations for Pharmacies
A possible concern with automating dispensing and constraining inventory to a narrow formulary is reducing pharmacist engagement to a brief transactional exchange, eroding the value of ongoing pharmacist–patient relationships. The kiosks are designed to provide immediate pharmacist access through direct call functionality and real-time video when legally required, aligning counseling with the clinical encounter. However, remote counseling tied to a single clinic encounter may not adequately capture patient history, adherence barriers, and medication-related concerns that often emerge through repeated, in-person interactions.
For physician practices and clinics, the kiosk model offers a potential patient experience differentiator but introduces operational complexity and compliance risk. Practices must weigh immediate fulfillment benefits against preserving individualized prescribing and robust pharmacist engagement. For pharmacies exploring their own kiosk deployments, these dynamics present both a competitive differentiator and a compliance challenge. A pharmacy operating a kiosk inside a clinic must ensure that its counseling model satisfies state Board of Pharmacy standards, which may require real-time audio-video capability, documented offer-to-counsel protocols, and pharmacist availability beyond the initial dispensing event.
A narrow on-site formulary also raises questions about prescribing influence: if a clinic partner steers prescriptions toward stocked medications, and the pharmacy benefits financially from that arrangement, the relationship must be carefully structured to avoid implicating the federal AKS. Even where no explicit remuneration changes hands, shared infrastructure, below-market lease terms, or preferential referral flows can create AKS exposure if not supported by a fair market value analysis and an applicable safe harbor. Pharmacies should also consider whether formulary limitations could give rise to patient safety concerns or state consumer protection issues if patients are not adequately informed about available alternatives.
Board of Pharmacy Compliance
Pharmacies deploying kiosk models must navigate their state Board of Pharmacy requirements. Core obligations include pharmacist verification of each prescription prior to dispensing, compliant labeling, secure medication storage, accurate dispensing records, and patient counseling for new prescriptions. Many states permit remote or telepharmacy counseling under defined conditions, but the specific requirements, such as real-time audio-video capability, documented patient refusal, or mandatory in-person consultation for certain drug classes, vary from state to state. Additionally, pharmacies must determine whether a kiosk constitutes a separate licensed pharmacy location, an extension of an existing permit, or an automated dispensing device subject to its own registration requirements. Many states restrict pharmacy ownership to licensed pharmacists or entities meeting specific corporate requirements, and a clinic-pharmacy kiosk arrangement must be structured to avoid violating these restrictions.
Anti-Kickback Statute Exposure
The financial relationship between a pharmacy and its clinic partner is a significant area of legal risk. The federal AKS prohibits offering, paying, soliciting, or receiving anything of value to induce or reward referrals of items or services payable by federal healthcare programs. In a kiosk arrangement, several common features can implicate the AKS: below-market rent for clinic space, revenue-sharing arrangements tied to prescription volume, exclusive dispensing agreements, or any preferential referral understanding between the clinic and the pharmacy. Pharmacies must ensure that lease arrangements reflect fair market value and are not determined in a manner that takes into account the volume or value of referrals. Where applicable, the parties should structure their relationship to satisfy a recognized safe harbor, such as the space rental or personal services safe harbors, which impose specific requirements around written agreements, fixed compensation, and commercially reasonable terms. Pharmacies should also be attentive to state anti-kickback and fee-splitting statutes, which may impose additional or different restrictions.
Pharmacy Benefit Manager Contracting Considerations
Pharmacies operating kiosk models must also evaluate their PBM network agreements. Many PBM contracts include provisions governing the pharmacy’s dispensing location, site-of-service classifications, and permissible dispensing methods. A pharmacy that begins dispensing from a kiosk inside a clinic may need to notify or obtain approval from its PBM partners, update its provider enrollment information, and confirm that kiosk-dispensed prescriptions are reimbursable under existing contract terms. Pharmacies should review whether their PBM agreements restrict dispensing through automated devices or impose additional requirements for remote dispensing sites. Failure to comply with network participation terms can result in claim denials, recoupment, or termination from the network. Additionally, pharmacies should consider how kiosk dispensing affects their reporting obligations, including any requirements related to usual and customary pricing, dispensing fees, and claims submission accuracy.
Additional Operational and Privacy Safeguards
Beyond BOP, AKS, and PBM considerations, pharmacies must implement privacy safeguards appropriate to the clinical setting, including secure identity verification, private consultation spaces or enclosed video terminals, and data handling protocols that satisfy HIPAA requirements for the transmission and storage of protected health information.
Failures in these areas can expose pharmacies and their clinic partners to regulatory enforcement, licensure risk, network termination, and fraud-and-abuse liability, even when the underlying care model is clinically sound. Pharmacies best positioned to succeed with kiosk-based dispensing will invest early in structuring compliant ownership and oversight models, conducting fair market value analyses of clinic relationships, confirming PBM contract compliance, and implementing robust counseling and privacy protocols.
How Frier Levitt Can Help
As pharmacy care models continue to evolve, point-of-care dispensing technologies such as clinic-based kiosks present both meaningful opportunities and complex compliance challenges. Implementing these models requires careful planning across regulatory, contractual, and operational considerations. Frier Levitt works with pharmacies to assess Board of Pharmacy requirements for automated dispensing and telepharmacy, evaluate AKS risk in clinic partnerships, and review PBM network agreements to ensure kiosk-based dispensing aligns with participation and reimbursement requirements.
Pharmacies that proactively address these issues will be better positioned to expand patient access to medications while minimizing regulatory exposure and operational risk. If your pharmacy is considering a clinic-based kiosk model, contact Frier Levitt to discuss how to structure the arrangement to support compliant operations and mitigate legal and reimbursement challenges.
